Abstract 186: Thyroid hormones as systemic regulators of melanoma progression and dissemination.
Helena Sterle(Pontificia Universidad Católica Argentina), Florencia Cayrol(Consejo Nacional de Investigaciones Científicas y Técnicas), Mercedes Debernardi(Instituto de Investigaciones Biomédicas en Retrovirus y Sida), Florencia Menay(Consejo Nacional de Investigaciones Científicas y Técnicas), María A. Paulazo(Consejo Nacional de Investigaciones Científicas y Técnicas), Graciela Cremaschi(Pontificia Universidad Católica Argentina), Lucero Alvarado(Pontificia Universidad Católica Argentina), G Gonzalez(Instituto de Investigaciones Biomédicas en Retrovirus y Sida)
Cited by 0
Related Papers
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors
|Nature Communications|2017|108
Immunomodulatory role of histamine H4 receptor in breast cancer
|British Journal of Cancer|2018|35
Thyroid status modulates T lymphoma growth via cell cycle regulatory proteins and angiogenesis
|Journal of Endocrinology|2014|22
Inhibition of Integrin αVβ3 Signaling Improves the Antineoplastic Effect of Bexarotene in Cutaneous T-Cell Lymphoma
|Molecular Cancer Therapeutics|2022|6
SUN-LB054 Cilengitide Reverts Thyroid Hormones Effects in Bexarotene Treatment of Breast Cancer Cells
|Journal of the Endocrine Society|2019|1